AUG 14, 2026 · PHASE 3 TRIAL
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
ClinicalTrials.gov
This is a clinical trial registry record with no reported results; the study is actively recruiting and outcomes have not yet been analysed or posted.
Reported
Estimated enrollment3003
Primary outcome measurePercent change in body weight from baseline…
Study phasePhase 3